Serum Institute seeks indemnity from liability; says 'rules should be same for everyone': Sources
''Rules should be the same for everyone,'' a source at the Serum Institute said.
In December 2020, speaking at an event, he said, ''we need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that''.
Serum Institute is producing Oxford-AstraZeneca's COVID vaccine 'Covishield' in India and clinical trials of its second vaccine 'Covovax' have begun in the country and the company hopes to launch it by September this year.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)